Fact CheckerSign in

NCT05762783Completed

The Importance of Sleep for Diabetes Associated Tasks and Outcomes

Source: ClinicalTrials.gov · Last updated 18 Apr 2024

Brief summary (registry, in English)

Adolescents with type 1 diabetes (T1D) experience more disturbed sleep compared to their healthy peers, especially because they tend to spend less time in deep sleep, the most restoring part of sleep, potentially impacting diabetes management. Disturbed sleep may adversely affect diabetes management which requires day-to-day decision-making, emotional and behavioural regulation, attention, and planning. Despite a massive increase in new technology, more than 50% of adolescents do not reach their glycaemic target. Lack of sleep impairing diabetes management including blood glucose monitoring may play an important role in reaching the goal. For approximately 4000 children and adolescents in Denmark living with T1D, sleep disturbances may therefore account for short and long-term diabetes complications. Our overall aims are to investigate: (1) If and how glycaemic variability (GV) influences sleep quality and sleep stages and (2) if and how poor sleep quality influences time-in-range (TIR), time-above-range (TAR) and time-below-range (TBR) the following day.

Status (registry)
Completed
Study type
Observational
Enrollment
77 (actual)
First submitted
16 Feb 2023
Start date
27 Mar 2023
Primary completion date
16 Apr 2024
Lead sponsor
Steno Diabetes Center Copenhagen
NCT number
NCT05762783

What you commit to

  • Study type: Observational
  • Participants enrolled: 77
  • From 27 Mar 2023 to the primary completion date, 16 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe psychiatric diseases using ICD-10 codes (e.g. ADHD, autism spectrum disorder, eating disorders, retarded mental development)

Other

  • Unwillingness to participate and inability to read and understand Danish or English.

Who the study is looking for

  • Type 1 diabetes for \> 6 months
  • Use of both insulin pump and continuous glucose monitor

Age in the registry: 6 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Steno Diabetes Center Copenhagen
Coordinator of this site? Confirm its status
HerlevDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.